Reading time: < 1 minute
The National Institute of General Medical Sciences (NIGMS) has awarded a $27 million, five-year contract to the Coriell Institute for Medical Research in Camden, N.J., to continue and expand operation of the NIGMS Human Genetic Cell Repository (HGCR). Under the new contract, the HGCR plans to enhance its collection of carefully maintained human cell lines by adding induced pluripotent stem (iPS) cells that carry disease gene mutations.
NIH Expands Network Focused On How Genes Affect Drug Responses
Brain Stent Fails to Prevent Strokes, NIH Stroke Prevention Trial has Immediate Implications for Clinical Practice
About the Author
